Skip to main content
ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
27.44
+0.89 (3.35%)
At close: Dec 5, 2025, 4:00 PM EST
27.60
+0.16 (0.58%)
After-hours: Dec 5, 2025, 7:59 PM EST

ACADIA Pharmaceuticals Revenue by Product
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
NUPLAZID
650.27M 639.20M 609.42M 590.42M 576.06M 560.67M 549.21M 541.81M
NUPLAZID Growth
12.88% 14.01% 10.96% 8.97% 9.17% 7.77% 6.17% 5.90%
DAYBUE
368.60M 357.07M 348.38M 338.78M 314.43M 253.10M - - - - - - - - - - - - -
DAYBUE Growth
17.23% 41.08% - - - - - - - - - - - - - - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.